Dr. Wise Young faces next hurdle to bringing long-awaited SCI clinical trials to reality

Andrew Skinner junio 9, 2020 Noticias, SCI

To watch the 70-year-old renowned researcher Dr. Wise Young talk about a lifetime of work to finally bring to the U.S. clinical trials of the umbilical cord blood mononuclear cell transplants for people with chronic and complete spinal cord injuries is both exhilarating as well as full of angst. The man who has devoted more than half his life to find the ultimate treatment, to help the segment of the SCI community that often feels forgotten and left behind, can see the finish line to the ultimate prize: to start the long-awaited clinical trials here in the U.S.


Comparte este artículo

    Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *